CVS Health(CH:CVS)
CH:CVS
CVS Health stock forecast
CVS Health (CVS) Stock Forecast & Price Target
1 Followers
CVS Analyst Ratings
Strong Buy
15Buy1Hold0Sell
Based on 16 analysts giving stock ratings to CVS Health in the past 3 months
CVS Stock 12 Month Forecast
Average Price Target
CHF91.60▲(0.00% Upside)Based on 16 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is CHF 91.60 with a high forecast of CHF 99.87 and a low forecast of CHF 83.23. The average price target represents a ― change from the last price of ―.
Highest Price TargetHighestCHF99.87Average Price TargetCHF91.60Lowest Price TargetLowestCHF83.23
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Stephen Baxter | Wells Fargo | CHF102.37→CHF93.21 | buy | ― | Assigned | 11/12/26 | ||
| Allen Lutz | Bank of America Securities | CHF83.23 | buy | ― | Reiterated | 11/10/26 | ||
| Scott Fidel | Goldman Sachs | CHF99.87→CHF95.71 | buy | ― | Reiterated | 11/06/26 | ||
| John Ransom | Raymond James | CHF99.87→CHF85.72 | buy | ― | Reiterated | 11/06/26 | ||
| Andrew Mok CFA | Barclays | CHF89.88→CHF89.05 | buy | ― | Reiterated | 11/05/26 | ||
| Erin Wright | Morgan Stanley | CHF92.38 | buy | ― | Assigned | 11/05/26 | ||
| Jessica Tassan | Piper Sandler | CHF94.04 | buy | ― | Reiterated | 11/05/26 | ||
 Unknown AnalystNot Ranked | Oppenheimer | ― | hold | ― | Reiterated | 11/05/26 | ||
| Kevin Caliendo | UBS | CHF98.21→CHF89.05 | buy | ― | Assigned | 11/05/26 | ||
| Michael Cherny | Leerink Partners | CHF93.21→CHF86.55 | buy | ― | Reiterated | 11/05/26 | ||
| Lance Wilkes | Bernstein | CHF93.21 | buy | ― | Reiterated | 11/04/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | CHF104.03→CHF91.55 | buy | ― | Assigned | 11/04/26 | ||
| Charles Rhyee | TD Cowen | CHF91.55 | buy | ― | Reiterated | 10/09/26 | ||
| Ben Hendrix | RBC Capital | CHF94.04 | buy | ― | Reiterated | 10/07/26 | ||
| Brian Tanquilut | Jefferies | CHF99.87 | buy | ― | Reiterated | 08/31/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Stephen BaxterWells Fargo | BuyAssignedCHF102.37→CHF93.21 | 11/12/26 | ― | ||
| Allen LutzBank of America Securities | BuyReiteratedCHF83.23 | 11/10/26 | ― | ||
| Scott FidelGoldman Sachs | BuyReiteratedCHF99.87→CHF95.71 | 11/06/26 | ― | ||
| John RansomRaymond James | BuyReiteratedCHF99.87→CHF85.72 | 11/06/26 | ― | ||
| Andrew Mok CFABarclays | BuyReiteratedCHF89.88→CHF89.05 | 11/05/26 | ― | ||
| Erin WrightMorgan Stanley | BuyAssignedCHF92.38 | 11/05/26 | ― | ||
| Jessica TassanPiper Sandler | BuyReiteratedCHF94.04 | 11/05/26 | ― | ||
| Unknown AnalystOppenheimerNot Ranked | HoldReiterated | 11/05/26 | ― | ||
| Kevin CaliendoUBS | BuyAssignedCHF98.21→CHF89.05 | 11/05/26 | ― | ||
| Michael ChernyLeerink Partners | BuyReiteratedCHF93.21→CHF86.55 | 11/05/26 | ― | ||
| Lance WilkesBernstein | BuyReiteratedCHF93.21 | 11/04/26 | ― | ||
| Elizabeth Anderson CFAEvercore ISI | BuyAssignedCHF104.03→CHF91.55 | 11/04/26 | ― | ||
| Charles RhyeeTD Cowen | BuyReiteratedCHF91.55 | 10/09/26 | ― | ||
| Ben HendrixRBC Capital | BuyReiteratedCHF94.04 | 10/07/26 | ― | ||
| Brian TanquilutJefferies | BuyReiteratedCHF99.87 | 08/31/26 | ― |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering CVS Health
3 Months
Success Rate18/27 ratings generated profit
67%
Average Return
+6.29%
Copying Elizabeth Anderson CFA's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +6.29% per trade.
1 Year
Success Rate20/27 ratings generated profit
74%
Average Return
+18.97%
Copying Elizabeth Anderson CFA's trades and holding each position for 1 Year would result in 74.07% of your transactions generating a profit, with an average return of +18.97% per trade.
2 Years
Success Rate26/30 ratings generated profit
87%
Average Return
+29.16%
Copying Allen Lutz's trades and holding each position for 2 Years would result in 86.67% of your transactions generating a profit, with an average return of +29.16% per trade.
CVS Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 |
| Buy | 37 | 36 | 35 | 32 | 25 |
| Hold | 1 | 1 | 1 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 38 | 37 | 36 | 32 | 27 |
In the current month, CVS has received 26 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CVS average Analyst price target in the past 3 months is 91.60.
CVS Financial Forecast
HighCHF1.12
ConsensusCHF0.92
LowCHF0.80
CVS Earnings Forecast
Next quarter’s earnings estimate for CVS is CHF 0.92 with a range of CHF 0.80 to CHF 1.12. The previous quarter’s EPS was CHF 1.73. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighCHF92.6B
ConsensusCHF88.6B
LowCHF86.6B
CVS Sales Forecast
Next quarter’s sales forecast for CVS is CHF 88.57B with a range of CHF 86.58B to CHF 92.60B. The previous quarter’s sales results were CHF 89.47B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
CVS Stock Forecast FAQ
What is CH:CVS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health’s 12-month average price target is CHF91.60.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CVS Health a Buy, Sell or Hold?
CVS Health has a consensus rating of Strong Buy, which is based on 15 buy ratings, 1 hold ratings and 0 sell ratings.
What is CVS Health’s share price target?
The average share price target for CVS Health is CHF91.60. This is based on 16 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF99.87, and the lowest forecast is CHF83.23. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about CVS Health?
CVS Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Street analysts.
How can I buy shares of CVS Health?
To buy shares of CH:CVS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
